Chemotherapy News and Research

Latest Chemotherapy News and Research

BCL-2 inhibitor shows promise in AML patients

Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2 inhibitor venetoclax (Venclexta), with complete remissions in some, according to phase II clinical trial data.

12 Aug 2016

Lancaster researchers develop new blood-testing technology to improve healthcare treatments

New blood-testing technology that promises to improve healthcare treatments for cancer patients, post-operative care and monitor the health of babies in the womb is being developed by Lancaster academics.

10 Aug 2016

Researchers develop computational algorithm to analyze big genomic data for different cancers

University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze "Big Data" obtained from tumor samples to better understand and treat cancer.

10 Aug 2016

Economic crisis linked to cancer mortality increase? An interview with Dr Mahiben Maruthappu

We found that the recent global economic crisis may have been associated with 260,000 additional cancer deaths in the OECD, between 2008 and 2010 alone.

9 Aug 2016

CTCA at Western begins clinical trial for novel antibody to treat patients with advanced tumors

Cancer Treatment Centers of America at Western Regional Medical Center has dosed its first three patients as part of the launch of a Phase I clinical trial using a novel antibody to treat patients with advanced solid tumors.

8 Aug 2016

Neuropathic pain could be significantly reduced by targeting brain cells

Neuropathic pain - which affects more than 1 million Americans - could be reduced or even eliminated by targeting brain cells that are supposed to provide immunity but, in some instances, do the opposite, causing chronic pain that could last a lifetime.

8 Aug 2016

Oncolytic virotherapy medicine shows positive treatment outcomes in late-stage cancer patients

The surprisingly positive treatment outcomes using Rigvir virotherapy for late stages cancer patients were recently published.

8 Aug 2016

Lack of insurance may increase risk of death in men with testicular cancer, study finds

Men with testicular cancer who were uninsured or on Medicaid had a higher risk of death from what is normally a curable disease than insured patients, a new study found.

8 Aug 2016

Reproductive age-related changes in ovarian environment may contribute to infertility

Women's decreased ability to produce healthy eggs as they become older may be due to excessive scarring and inflammation in their ovaries, reports a new Northwestern Medicine study in mice.

8 Aug 2016

Studies show insurance status may impact patients' health outcomes following cancer diagnosis

Two new studies indicate that health insurance status may impact patients' health outcomes following a diagnosis of cancer.

8 Aug 2016

Scientists develop novel multifunctional platform to integrate imaging and photo-induced cancer therapy

Physicists from The University of Texas at Arlington are leading a multidisciplinary project with The University of Texas Southwestern Medical Center in Dallas and The University of Texas MD Anderson Cancer Center in Houston to develop a new multifunctional platform that can integrate imaging and photo-induced cancer therapy in a single, portable device.

5 Aug 2016

Wistar scientists discover marker for PMN-MDSCs in the blood of cancer patients

Myeloid-derived suppressor cells (MDSCs) are a population of immune cells that have been implicated in tumor resistance to various types of cancer treatment, including targeted therapies, chemotherapy and immunotherapy.

5 Aug 2016

Penn researchers develop computer model for designing drug-delivery nanocarriers

A team of University of Pennsylvania researchers has developed a computer model that will aid in the design of nanocarriers, microscopic structures used to guide drugs to their targets in the body.

5 Aug 2016

Researchers develop method to kill cancer cells using nanoparticles and lasers

Cancer treatments based on laser irridation of tiny nanoparticles that are injected directly into the cancer tumor are working and can destroy the cancer from within.

4 Aug 2016

Advances in head and neck cancer treatments: an interview with Prof. Argiris

Patients with head and neck cancer usually present with locally advanced disease and often require more than one type of treatment, which may include surgery, radiotherapy, and chemotherapy.

3 Aug 2016

Scientists develop model using transformed stem cells to accelerate screening of drugs for rare cancers

Researchers at the Johns Hopkins Kimmel Cancer Center say they have developed a system that uses transformed human stem cells to speed up screening of existing drugs that might work against rare brain and other cancers.

2 Aug 2016

New drug prevents vaginal and oral transmission of HIV in pre-clinical animal models

HIV remains a major health concern for women and children globally. Worldwide, the majority of new HIV infections occur in young women. Each year, 1.5 million women living with HIV become pregnant.

2 Aug 2016

Roche announces FDA approval of new VENTANA PD-L1 assay

Roche today announced approval of the VENTANA PD-L1 (SP142) Assay by the US Food and Drug Administration as a complementary diagnostic to provide PD-L1 status on patients who are considering treatment with the FDA approved Roche immunotherapy TECENTRIQ™ (atezolizumab) for metastatic urothelial cancer (mUC).

30 Jul 2016

Triple-combination therapy patch shrinks tumors, prevents recurrence in colon cancer mice model

Investigators at Brigham and Women's Hospital have developed a hydrogel patch that can adhere to tumors in a preclinical model of colon cancer, delivering a local, combination treatment as the elastic gel breaks down over time.

29 Jul 2016

T-cell technology could be used to treat ovarian tumors with no adverse effects

With only incremental improvements in ovarian cancer survival over the last 40 years, there is a clear need for new treatment options with long-lasting results. Many researchers have turned toward the development of immunotherapies that direct T-cells to selectively eliminate ovarian tumor cells, but an appropriate therapeutic target for ovarian cancers has remained elusive.

29 Jul 2016

Chemotherapy News and Research

Latest Chemotherapy News and Research

BCL-2 inhibitor shows promise in AML patients

Lancaster researchers develop new blood-testing technology to improve healthcare treatments

Researchers develop computational algorithm to analyze big genomic data for different cancers

Economic crisis linked to cancer mortality increase? An interview with Dr Mahiben Maruthappu

CTCA at Western begins clinical trial for novel antibody to treat patients with advanced tumors

Neuropathic pain could be significantly reduced by targeting brain cells

Oncolytic virotherapy medicine shows positive treatment outcomes in late-stage cancer patients

Lack of insurance may increase risk of death in men with testicular cancer, study finds

Reproductive age-related changes in ovarian environment may contribute to infertility

Studies show insurance status may impact patients' health outcomes following cancer diagnosis

Scientists develop novel multifunctional platform to integrate imaging and photo-induced cancer therapy

Wistar scientists discover marker for PMN-MDSCs in the blood of cancer patients

Penn researchers develop computer model for designing drug-delivery nanocarriers

Researchers develop method to kill cancer cells using nanoparticles and lasers

Advances in head and neck cancer treatments: an interview with Prof. Argiris

Scientists develop model using transformed stem cells to accelerate screening of drugs for rare cancers

New drug prevents vaginal and oral transmission of HIV in pre-clinical animal models

Roche announces FDA approval of new VENTANA PD-L1 assay

Triple-combination therapy patch shrinks tumors, prevents recurrence in colon cancer mice model

T-cell technology could be used to treat ovarian tumors with no adverse effects

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in